טוען...
Results of a phase Ib trial of combination immunotherapy with a CD8+ T cell eliciting vaccine and trastuzumab in breast cancer patients
BACKGROUND: CD8+ T cell-eliciting vaccines are being investigated in breast cancer patients. Preclinical data showed that trastuzumab increases the susceptibility of tumor cells to lysis by vaccine-generated CD8+ T cells suggesting potential benefit of a combination immunotherapy strategy. The curre...
שמור ב:
| הוצא לאור ב: | Ann Surg Oncol |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5908243/ https://ncbi.nlm.nih.gov/pubmed/28315060 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-017-5844-0 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|